Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Goodwill (2019 - 2025)

Biodesix (BDSX) has disclosed Goodwill for 7 consecutive years, with $15.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Goodwill changed 0.0% year-over-year to $15.0 million, compared with a TTM value of $15.0 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $15.0 million, changed 0.0% over the prior year.
  • Goodwill was $15.0 million for Q4 2025 at Biodesix, roughly flat from $15.0 million in the prior quarter.
  • Across five years, Goodwill topped out at $15.0 million in Q1 2021 and bottomed at $15.0 million in Q1 2021.
  • Average Goodwill over 5 years is $15.0 million, with a median of $15.0 million recorded in 2021.
  • Peak annual rise in Goodwill hit 29.23% in 2021, while the deepest fall reached 0.0% in 2021.
  • Year by year, Goodwill stood at $15.0 million in 2021, then changed by 0.0% to $15.0 million in 2022, then changed by 0.0% to $15.0 million in 2023, then changed by 0.0% to $15.0 million in 2024, then changed by 0.0% to $15.0 million in 2025.
  • Business Quant data shows Goodwill for BDSX at $15.0 million in Q4 2025, $15.0 million in Q3 2025, and $15.0 million in Q2 2025.